Bioprocessing Needs to Move Fast and NOT Break Things
Genentech’s biomanufacturing plant in Vacaville, CA, covers more than 427,000 square feet of space and produces pharmaceutical proteins from mammalian cells. To ensure that the plant consistently produces safe, high-quality biologics, the company has developed platform technologies that can coordinate analytical, characterization, and control activities.
NOT Break Things
To deliver novel biotherapeutics more quickly while managing financial risks and regulatory demands, biomanufacturers are adopting technologies that promote highly integrated operations
May 3, 2021
Genentech’s biomanufacturing plant in Vacaville, CA, covers more than 427,000 square feet of space and produces pharmaceutical proteins from mammalian cells. To ensure that the plant consistently produces safe, high-quality biologics, the company has developed platform technologies that can coordinate analytical, characterization, and control activities.